Page last updated: 2024-09-05

zm 241385 and Hypertension

zm 241385 has been researched along with Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borea, PA; Cattabriga, E; Iannotta, V; Manfredini, R; Pancaldi, C; Portaluppi, F; Uluoglu, C; Varani, K1
Brooks, R; Keddie, JR; McKillop, D; Poucher, SM; Shaw, GR1

Trials

1 trial(s) available for zm 241385 and Hypertension

ArticleYear
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6

    Topics: Adenosine-5'-(N-ethylcarboxamide); Adult; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Body Mass Index; Cyclic AMP; Diastole; Doxazosin; Female; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Neutrophils; Propranolol; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reference Values; Systole; Treatment Outcome; Triazines; Triazoles

2002

Other Studies

1 other study(ies) available for zm 241385 and Hypertension

ArticleYear
Pharmacodynamics of ZM 241385, a potent A2a adenosine receptor antagonist, after enteric administration in rat, cat and dog.
    The Journal of pharmacy and pharmacology, 1996, Volume: 48, Issue:6

    Topics: Administration, Oral; Animals; Cats; Dogs; Drug Interactions; Female; Hemodynamics; Hypertension; Injections, Intravenous; Intubation, Gastrointestinal; Male; Purinergic P1 Receptor Antagonists; Rats; Species Specificity; Theophylline; Triazines; Triazoles; Vasodilation; Vasodilator Agents

1996